1. Home
  2. NREF vs ELTX Comparison

NREF vs ELTX Comparison

Compare NREF & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Real Estate Finance Inc.

NREF

NexPoint Real Estate Finance Inc.

HOLD

Current Price

$13.15

Market Cap

244.2M

Sector

Real Estate

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$11.67

Market Cap

209.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NREF
ELTX
Founded
2019
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
244.2M
209.9M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
NREF
ELTX
Price
$13.15
$11.67
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$14.50
$17.00
AVG Volume (30 Days)
47.9K
131.0K
Earning Date
01-01-0001
06-22-2026
Dividend Yield
14.94%
N/A
EPS Growth
N/A
39.29
EPS
N/A
N/A
Revenue
N/A
$2,301,000.00
Revenue This Year
$24.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.14
$4.60
52 Week High
$16.80
$14.93

Technical Indicators

Market Signals
Indicator
NREF
ELTX
Relative Strength Index (RSI) 30.46 55.17
Support Level $12.36 $7.78
Resistance Level $15.25 $11.82
Average True Range (ATR) 0.43 1.25
MACD -0.17 -0.11
Stochastic Oscillator 3.74 23.76

Price Performance

Historical Comparison
NREF
ELTX

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: